9-137436101-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001033113.2(ENTPD8):c.962G>A(p.Arg321Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,612,902 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001033113.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ENTPD8 | NM_001033113.2 | c.962G>A | p.Arg321Gln | missense_variant | 7/10 | ENST00000371506.7 | NP_001028285.1 | |
ENTPD8 | NM_198585.3 | c.962G>A | p.Arg321Gln | missense_variant | 7/9 | NP_940987.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ENTPD8 | ENST00000371506.7 | c.962G>A | p.Arg321Gln | missense_variant | 7/10 | 5 | NM_001033113.2 | ENSP00000360561 | P1 | |
ENTPD8 | ENST00000344119.6 | c.962G>A | p.Arg321Gln | missense_variant | 7/9 | 1 | ENSP00000344089 | |||
ENTPD8 | ENST00000461823.1 | n.1760G>A | non_coding_transcript_exon_variant | 5/8 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152222Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 250286Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135728
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1460680Hom.: 0 Cov.: 33 AF XY: 0.0000275 AC XY: 20AN XY: 726658
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152222Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74370
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 15, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at